We are live on ! Find out more
Segall Bryant & Hamill

Segall Bryant & Hamill Portfolio holdings

AUM $7.55B Turnover 18.73%
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
-3.66%
1 Year Est. Return
+31.98%
3 Year Est. Return
+113.59%
5 Year Est. Return
+129.59%
10 Year Est. Return
+500.39%
AUM
$7.55B
AUM Growth
-$878M
Cap. Flow
-$267M
Cap. Flow %
-3.53%
Top 10 Hldgs %
13.37%
Holding
646
New
56
Increased
140
Reduced
329
Closed
65
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$45.5M
2
TKR icon
Timken
TKR
+$21.3M
3
KAI icon
Kadant
KAI
+$18.2M
4
COST icon
Costco
COST
+$18.1M
5
KWR icon
Quaker Houghton
KWR
+$18.1M

Top Sells

Rank Stock Value
1
MKSI icon
MKS
MKSI
+$39.4M
2
MTSI icon
MACOM Technology Solutions
MTSI
+$35.1M
3
MTRN icon
Materion
MTRN
+$35.1M
4
DBRG icon
DigitalBridge
DBRG
+$25.6M
5
PDFS icon
PDF Solutions
PDFS
+$24.6M

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Industrials 20.41%
3 Financials 13.61%
4 Healthcare 13.2%
5 Consumer Discretionary 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SSD icon
151
Simpson Manufacturing
SSD
$7.99B
$17.4M 0.23%
102,072
-58,840
-37% -$10.9M
2022 Q4
15 quarters
CXT icon
152
Crane NXT
CXT
$3.19B
$17.3M 0.23%
367,402
+22,434
+7% +$1.13M
2020 Q4
23 quarters
NFLX icon
153
Netflix
NFLX
$246B
$17.2M 0.23%
247,598
-18,682
-7% -$1.4M
2024 Q3
8 quarters
MOH icon
154
Molina Healthcare
MOH
$10.8B
$17.1M 0.23%
90,267
-50,440
-36% -$10.4M
2026 Q1
2 quarters
PTCT icon
155
PTC Therapeutics
PTCT
$5.03B
$17M 0.23%
262,883
-8,852
-3% -$645K
2025 Q2
5 quarters
KRYS icon
156
Krystal Biotech
KRYS
$9.34B
$16.7M 0.22%
50,221
-14,990
-23% -$5.19M
2024 Q2
9 quarters
RMBS icon
157
Rambus
RMBS
$8.45B
$16.5M 0.22%
154,735
-5,558
-3% -$536K
2024 Q4
7 quarters
RVLV icon
158
Revolve Group
RVLV
$1.38B
$16.5M 0.22%
772,244
-27,755
-3% -$643K
2025 Q1
6 quarters
OGS icon
159
ONE Gas
OGS
$5.19B
$16.4M 0.22%
228,844
+196,646
+611% +$15.4M
2025 Q1
6 quarters
OTIS icon
160
Otis Worldwide
OTIS
$29.6B
$16.4M 0.22%
255,462
-30,072
-11% -$2.14M
2026 Q1
2 quarters
CYTK icon
161
Cytokinetics
CYTK
$7.15B
$16.4M 0.22%
248,358
-8,705
-3% -$664K
2024 Q2
9 quarters
GKOS icon
162
Glaukos
GKOS
$13.8B
$16.4M 0.22%
99,624
-68,821
-41% -$11.5M
2023 Q4
11 quarters
NEO icon
163
NeoGenomics
NEO
$1.98B
$16.3M 0.22%
887,340
-199,056
-18% -$3.28M
2022 Q3
16 quarters
VYMI icon
164
Vanguard International High Dividend Yield ETF
VYMI
$21.2B
$16.3M 0.22%
160,950
+294
+0.2% +$30.4K
2025 Q4
3 quarters
WTFC icon
165
Wintrust Financial
WTFC
$10.1B
$16.1M 0.21%
113,605
-943
-0.8% -$147K
2026 Q1
2 quarters
KAI icon
166
Kadant
KAI
$3.43B
$15.8M 0.21%
+60,415
New +$18.2M
2026 Q3
0 quarters
MDGL icon
167
Madrigal Pharmaceuticals
MDGL
$9.25B
$15.8M 0.21%
31,322
-1,122
-3% -$593K
2025 Q3
4 quarters
ESE icon
168
ESCO Technologies
ESE
$5.92B
$15.8M 0.21%
59,473
-2,132
-3% -$633K
2025 Q4
3 quarters
AMKR icon
169
Amkor Technology
AMKR
$8.75B
$15.7M 0.21%
300,619
-27,378
-8% -$1.52M
2024 Q2
9 quarters
SLGN icon
170
Silgan Holdings
SLGN
$4.29B
$15.7M 0.21%
451,851
-68,565
-13% -$2.86M
2013 Q2
53 quarters
AAP icon
171
Advance Auto Parts
AAP
$2.79B
$15.5M 0.21%
399,413
-2,360
-0.6% -$118K
2024 Q4
7 quarters
ATR icon
172
AptarGroup
ATR
$8.98B
$15.5M 0.21%
128,262
-8,369
-6% -$1.08M
2025 Q1
6 quarters
NHI icon
173
National Health Investors
NHI
$3.07B
$15.5M 0.21%
236,454
+27,160
+13% +$1.99M
2026 Q2
1 quarter
MIR icon
174
Mirion Technologies
MIR
$4.28B
$15.4M 0.2%
1,091,863
-39,261
-3% -$621K
2024 Q2
9 quarters
CASY icon
175
Casey's General Stores
CASY
$25.8B
$15.4M 0.2%
25,283
-512
-2% -$395K
2018 Q1
34 quarters

Similar funds

Segall Bryant & Hamill's Q3 2026 Portfolio in Review

As of Q3 2026, Segall Bryant & Hamill held 646 positions worth $7.55B, down 10% from $8.43B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Segall Bryant & Hamill withdrew a net $267M in Q3 2026, closing 65 positions and reducing 329 holdings. Its most notable exit was MKS, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Financials.

Against the trend, Segall Bryant & Hamill opened a new position in Avantor worth $51M.

  • Segall Bryant & Hamill's largest Q3 2026 buy was Avantor: 3,390,641 shares worth $51M.
  • Segall Bryant & Hamill added most to Timken in Q3 2026, an estimated $21.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2026 reduction was MACOM Technology Solutions, cutting an estimated $35.1M.
  • Segall Bryant & Hamill fully exited MKS in Q3 2026, selling an estimated $39.4M.
  • Segall Bryant & Hamill's ten largest holdings make up 13% of its $7.55B portfolio in Q3 2026.
  • Segall Bryant & Hamill opened 56 new positions and closed 65 in Q3 2026.
  • Segall Bryant & Hamill's portfolio value fell 10% quarter-over-quarter to $7.55B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2026, filed 16 Nov 2026.